Wntß-Catenin : A New Therapeutic Approach to Acute Myeloid Leukemia
Joint Authors
Kim, Y.
Thanendrarajan, S.
Schmidt-Wolf, Ingo G. H.
Source
Leukemia Research and Treatment
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-12-01
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Mechanical Engineering
Medicine
Abstract EN
Recent studies have shown genetic and epigenetic aberrations resulting in aberrant activation of the Wingless-Int (Wnt) pathway, thus influencing the initiation and progression of acute myeloid leukemia (AML).
Of major importance, these findings may lead to novel treatment strategies exploiting targeted modulation of Wnt signaling.
This paper comprises the latest status of knowledge concerning the role of Wnt pathway alteration in AML and outlines future lines of research and their clinical perspectives.
American Psychological Association (APA)
Kim, Y.& Thanendrarajan, S.& Schmidt-Wolf, Ingo G. H.. 2011. Wntß-Catenin : A New Therapeutic Approach to Acute Myeloid Leukemia. Leukemia Research and Treatment،Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-471523
Modern Language Association (MLA)
Kim, Y.…[et al.]. Wntß-Catenin : A New Therapeutic Approach to Acute Myeloid Leukemia. Leukemia Research and Treatment No. 2011 (2011), pp.1-4.
https://search.emarefa.net/detail/BIM-471523
American Medical Association (AMA)
Kim, Y.& Thanendrarajan, S.& Schmidt-Wolf, Ingo G. H.. Wntß-Catenin : A New Therapeutic Approach to Acute Myeloid Leukemia. Leukemia Research and Treatment. 2011. Vol. 2011, no. 2011, pp.1-4.
https://search.emarefa.net/detail/BIM-471523
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-471523
